Philips

Intracardiac Echocardiography Devices Market size to grow by USD 11.5 billion from 2022 to 2030; Increasing number of heart-related medical conditions and treatments to boost the market growth - Facts & Factor

Retrieved on: 
Wednesday, June 28, 2023
Heart, Ventricular septal defect, Mayo Clinic, Left atrial appendage occlusion, Life, ICE, Catheter, Hospital, Philips, Patient, Investment, Electrophysiology, TEE, Universal health care, UHC, Growth, Clinical professor, Medical imaging, Health care

Global Intracardiac Echocardiography Devices Market: Growth Drivers

Key Points: 
  • Global Intracardiac Echocardiography Devices Market: Growth Drivers
    Increasing number of heart-related medical conditions and treatments to propel market growth.
  • The global intracardiac echocardiography devices market is projected to grow owing to the increasing number of patients suffering from heart-related conditions and their subsequent treatment.
  • Most traditional tools like transoesophageal echocardiography (TEE) are used to prepare for and act as guiding tools during interventional treatment.
  • Global Intracardiac Echocardiography Devices Market: Segmentation
    The global intracardiac echocardiography devices market is segmented based on end-user, application, and region.

Moa Netto Named Head of Creative, Americas for Social Transformation™ Company, 1000heads

Retrieved on: 
Monday, June 26, 2023
IBM, Ogilvy, D, Cannes Lions International Festival of Creativity, Head, DDB, Lion, BBDO, Keurig, RAPP, SAP, Woodley, Eli Lilly, Creativity, Amazon, Coke, Volkswagen, Allianz, Social Age, Ogilvy (agency), Unikrn, Creative, Intel, Moa, Growth, Verizon Communications, Philips, Social, Clio Awards, Data Analytics Library, Netto, Creative industries, Industrial design, Logitech, Audi, Spectrum

NEW YORK , June 26, 2023 /PRNewswire/ -- 1000heads has hired Moa Netto as Head of Creative for the Americas. 1000heads is a Social Transformation™ company that combines expertise in data & analytics, strategy, technology and creativity to help the world's best businesses build Social Age brands. 1000heads are the Strategy Agency of Record for Google Hardware and Influencer Agency of Record for Verizon, and recently won Social Agency of Record for Logitech.

Key Points: 
  • NEW YORK , June 26, 2023 /PRNewswire/ -- 1000heads has hired Moa Netto as Head of Creative for the Americas.
  • 1000heads, a global leader in social and influencer strategy, has hired Moa Netto as Head of Creative for the Americas.
  • Netto joins as 1000heads' first Head of Creative across both North and South America.
  • "Moa has a proven track record of delivering ideas that naturally drive conversation," said Adam Woodley, Managing Director, Americas for 1000heads.

Wearable Medical Device Market to Hit $168.2 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Thursday, June 22, 2023
Garmin, Telehealth, Obesity, Philips, COVID-19, Diagnosis, Electronics, USD, Mobile device, Incidence, Patient, Application, Physician, SAN, Growth, Polar Electro, Apple, Physical fitness, Artificial intelligence, Nike, WHO, Heart rate, Skin temperature, Medical device, Fitbit, Withings, Covidien

Straps, clip, bracelets & watches are the largest and fastest growing segment for wearable medical devices.

Key Points: 
  • Straps, clip, bracelets & watches are the largest and fastest growing segment for wearable medical devices.
  • Read 150-page market research report, " Wearable Medical Device Market Size, Share & Trends Analysis Report By Product (Diagnostic, Therapeutic Devices), By Site (Handheld, Headband, Strap, Shoe Sensors), By Application, By Region And Segment Forecasts, 2023 - 2030 ", published by Grand View Research.
  • The COVID-19 pandemic somehow has a positive impact on wearable medical device market owing to increasing demand for telemedicine.
  • Growth of telemedicine and expansion of applications to integrate artificial intelligence (AI) in its systems has led to wearable medical device market growth.

Wearable Medical Device Market to Hit $168.2 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Thursday, June 22, 2023
Garmin, Telehealth, Obesity, Philips, COVID-19, Diagnosis, Electronics, USD, Mobile device, Incidence, Patient, Application, Physician, SAN, Growth, Polar Electro, Apple, Physical fitness, Artificial intelligence, Nike, WHO, Heart rate, Skin temperature, Medical device, Fitbit, Withings, Covidien

Straps, clip, bracelets & watches are the largest and fastest growing segment for wearable medical devices.

Key Points: 
  • Straps, clip, bracelets & watches are the largest and fastest growing segment for wearable medical devices.
  • Read 150-page market research report, " Wearable Medical Device Market Size, Share & Trends Analysis Report By Product (Diagnostic, Therapeutic Devices), By Site (Handheld, Headband, Strap, Shoe Sensors), By Application, By Region And Segment Forecasts, 2023 - 2030 ", published by Grand View Research.
  • The COVID-19 pandemic somehow has a positive impact on wearable medical device market owing to increasing demand for telemedicine.
  • Growth of telemedicine and expansion of applications to integrate artificial intelligence (AI) in its systems has led to wearable medical device market growth.

Cyclomedia, Global Leader in Geospatial Data Technology announces appointments to Executive Team

Retrieved on: 
Thursday, June 22, 2023
TomTom, CFO, Growth, Commercial, Electronics, Consumer electronics, Philips, Intertrust Group, Management, Surveying, CycloMedia

ZALTBOMMEL, Netherlands, June 22, 2023 /PRNewswire/ -- Cyclomedia , global leader in geospatial data technology announces the addition of two highly experienced industry players to their executive team.

Key Points: 
  • ZALTBOMMEL, Netherlands, June 22, 2023 /PRNewswire/ -- Cyclomedia , global leader in geospatial data technology announces the addition of two highly experienced industry players to their executive team.
  • Both appointments bring a wealth of insight and experience at a time when Cyclomedia seeks to scale-up and further penetrate in various industry verticals.
  • Rogier's background is highly internationally focused, having worked in the Netherlands, USA and China, developing a robust portfolio of experience in technology and private equity.
  • Sean brings substantial experience in geospatial technology and a unique blend of expertise in several key Cyclomedia business areas, such as large-scale, high-accuracy 3D imagery.

Cyclomedia, Global Leader in Geospatial Data Technology announces appointments to Executive Team

Retrieved on: 
Thursday, June 22, 2023
TomTom, CFO, Growth, Commercial, Electronics, Consumer electronics, Philips, Intertrust Group, Management, Surveying, CycloMedia

ZALTBOMMEL, Netherlands, June 22, 2023 /PRNewswire/ -- Cyclomedia , global leader in geospatial data technology announces the addition of two highly experienced industry players to their executive team.

Key Points: 
  • ZALTBOMMEL, Netherlands, June 22, 2023 /PRNewswire/ -- Cyclomedia , global leader in geospatial data technology announces the addition of two highly experienced industry players to their executive team.
  • Both appointments bring a wealth of insight and experience at a time when Cyclomedia seeks to scale-up and further penetrate in various industry verticals.
  • Rogier's background is highly internationally focused, having worked in the Netherlands, USA and China, developing a robust portfolio of experience in technology and private equity.
  • Sean brings substantial experience in geospatial technology and a unique blend of expertise in several key Cyclomedia business areas, such as large-scale, high-accuracy 3D imagery.

Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics

Retrieved on: 
Thursday, June 22, 2023
Drug development, Therapy, Neoplasm, Therapeutic index, Cancer, CMO, Radiopharmaceutical, Antibody, Oost, Chemistry, NEA, Doctor of Philosophy, Standard of care, Philips, Patient, Peptide, Eagles in Middle-earth, Chairperson, ADC, Spacecraft, Tumor microenvironment, Safety, Fine chemical, Pharmaceutical industry, Vaccine, New Enterprise Associates

NIJMEGEN, Netherlands and BOSTON, June 22, 2023 /PRNewswire/ -- Tagworks Pharmaceuticals BV ("Tagworks"), the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates (NEA), and Lightstone Ventures. They join existing investors including Meneldor and Oost NL. In conjunction with the financing, Thomas Harth (Ysios Capital), Edwin de Graaf (Gilde Healthcare), Marianne Uteng, Ph.D. (Novartis Venture Fund), Michele Park, Ph.D. (NEA), and Christina Isacson, Ph.D. (Lightstone Ventures), joined the Board of Directors.

Key Points: 
  • The financing will support the advancement of TGW101, Tagworks' lead click-cleavable ADC program, and the company's proprietary Click-to-Release platform.
  • Tagworks' platform enables controlled drug release induced by an in vivo click reaction with a trigger molecule.
  • Thomas Harth, Principal at Ysios Capital stated: "We are proud to have assembled such a strong, international syndicate of investors around Tagworks.
  • The ability to enable on-target activation or off-target deactivation is a potentially game-changing opportunity in the field of drug development.

Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics

Retrieved on: 
Thursday, June 22, 2023
Drug development, Therapy, Neoplasm, Therapeutic index, Cancer, CMO, Radiopharmaceutical, Antibody, Oost, Chemistry, NEA, Doctor of Philosophy, Standard of care, Philips, Patient, Peptide, Eagles in Middle-earth, Chairperson, ADC, Spacecraft, Tumor microenvironment, Safety, Fine chemical, Pharmaceutical industry, Vaccine, New Enterprise Associates

NIJMEGEN, Netherlands and BOSTON, June 22, 2023 /PRNewswire/ -- Tagworks Pharmaceuticals BV ("Tagworks"), the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates (NEA), and Lightstone Ventures. They join existing investors including Meneldor and Oost NL. In conjunction with the financing, Thomas Harth (Ysios Capital), Edwin de Graaf (Gilde Healthcare), Marianne Uteng, Ph.D. (Novartis Venture Fund), Michele Park, Ph.D. (NEA), and Christina Isacson, Ph.D. (Lightstone Ventures), joined the Board of Directors.

Key Points: 
  • The financing will support the advancement of TGW101, Tagworks' lead click-cleavable ADC program, and the company's proprietary Click-to-Release platform.
  • Tagworks' platform enables controlled drug release induced by an in vivo click reaction with a trigger molecule.
  • Thomas Harth, Principal at Ysios Capital stated: "We are proud to have assembled such a strong, international syndicate of investors around Tagworks.
  • The ability to enable on-target activation or off-target deactivation is a potentially game-changing opportunity in the field of drug development.

Philips Norelco Unveils Team OneBlade 2023, featuring top professional basketball prospects Gradey Dick, Keyonte George and Jarace Walker

Retrieved on: 
Wednesday, June 21, 2023
The Beauty Market, Sport, Athlete, 2000s, Hair, Philips, Growth, Team, Face, Cassette tape, Entertainment

STAMFORD, Conn., June 21, 2023 /PRNewswire/ -- Philips, a global leader in health technology, today introduces the second annual class of Philips Norelco Team OneBlade. The new collective of rising professional basketball prospects will prepare for draft night and the next chapter in their athletic careers with the new Philips Norelco OneBlade 360, a hybrid electric shaver and trimmer that can trim, edge and shave any length of hair. Team OneBlade welcomes an all-star trio of talent: Gradey Dick, Keyonte George and Jarace Walker.

Key Points: 
  • STAMFORD, Conn., June 21, 2023 /PRNewswire/ -- Philips , a global leader in health technology, today introduces the second annual class of Philips Norelco Team OneBlade.
  • Team OneBlade welcomes an all-star trio of talent: Gradey Dick, Keyonte George and Jarace Walker.
  • Similar to the on-court versatility of the Team OneBlade players, Philips Norelco OneBlade 360 is versatile enough to trim, edge and shave any length of hair.
  • For behind-the-scenes content about how Team OneBlade is getting ready for the big night, follow along with Team OneBlade athletes on their social channels and Philips Norelco on Instagram .

SEED Therapeutics, BeyondSpring Subsidiary, Appoints Jackson Tai to Board of Directors

Retrieved on: 
Tuesday, June 20, 2023
HSBC, Bachelor, J. P. Morgan, Vice, Bachelor of Science, Capital market, Harvard University, Vulnerability and Risk Committee, Metropolitan, Audit committee, Risk management, NYSE Euronext, Metropolitan Opera, TPD, Council, SEED, Eli Lilly, Senior officer, Business administration, WuXi Biologics, Singapore Airlines, Philips, Rensselaer Polytechnic Institute, Hong Kong Exchanges and Clearing, Engineering, Bank, Harvard Business School, Foreign policy, Management, How I Braved Anu Aunty and Co-Founded a Million Dollar Company, Bank of China, DBS Bank, Entrepreneurship, Therapy, CPP Investment Board, Master of Business Administration, Pharmaceutical industry, Mastercard

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- SEED Therapeutics (the “Company”), a BeyondSpring (NASDAQ: BYSI) subsidiary and global research company focused on harnessing and engineering “molecular glues,” a targeted protein degradation (TPD) platform to attack previously believed undruggable targets, today announced that it has appointed Jackson Tai to its Board of Directors. Mr. Tai has most recently retired, or will soon retire, as a Non-Executive Director of Eli Lilly (after 10 years), HSBC (after 7 years), and Mastercard (after 15 years). He brings almost 50 years’ experience in finance, strategy, and risk governance to the SEED Therapeutics Board.

Key Points: 
  • He brings almost 50 years’ experience in finance, strategy, and risk governance to the SEED Therapeutics Board.
  • He continues to serve as Board Member for Hong Kong Exchange listed Wuxi Biologics (where he is Chairman of the Audit Committee).
  • “It is a privilege to join the SEED Therapeutics Board and to work alongside our Co-Founding scientists and visionaries who are recognized pioneers in the field of Targeted Protein Degradation,” said Mr. Tai.
  • It’s truly exciting to see Management, the Board, and Co-Founders to be so obsessed with SEED Therapeutics’ opportunity to be First to Market and Best in Class.”